PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

• Status: Completed
• Trial end date: 2019-01-01

Summary

Positron emission tomography (PET) imaging evaluation in men with recurrent prostate cancer to select patients who may benefit from directed therapy

• Phase: Phase 2

Details

• Lead Sponsor: Phoenix Molecular Imaging